Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8800Fax+1 214-648-6410
Summary
- Academic Neurointensivist and Clinical Ethicist
Education & Training
- Loyola University ChicagoMA, Bioethics and Health Policy, 2013
- University of Texas Southwestern Medical CenterResidency, Neurology, 2005 - 2008
- John Peter Smith Hospital (Tarrant County Hospital District)Internship, Transitional Year, 2004 - 2005
- Texas Tech University Health Sciences Center School of MedicineClass of 2004
- University of Texas at Austin: College of Liberal ArtsBA, Plan II Honors Liberal Arts Program, 1998
Certifications & Licensure
- TX State Medical License 2013 - 2026
- MO State Medical License 2008 - 2014
- American Board of Psychiatry and Neurology Neurology
- UCNSNeurocritical Care
Awards, Honors, & Recognition
- Presidential Service Award Neurocritical Care Society, 2015
- Presidential Citation Neurocritical Care Society, 2015
Publications & Presentations
PubMed
- 1 citationsEquity in Clinical Care and Research Involving Persons with Disorders of Consciousness.Michael A Rubin, Ariane Lewis, Claire J Creutzfeldt, Gentle S Shrestha, Quinn Boyle
Neurocritical Care. 2024-10-01 - Beyond the Final Heartbeat: Neurological Perspectives on Normothermic Regional Perfusion for Organ Donation after Circulatory Death.Matthew P Kirschen, Ariane Lewis, Michael A Rubin, Panayiotis N Varelas, David M Greer
Annals of Neurology. 2024-06-01 - 26 citationsPediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline.David M Greer, Matthew P Kirschen, Ariane Lewis, Gary S Gronseth, Alexander Rae-Grant
Neurology. 2023-12-12
Books/Book Chapters
Lectures
- Racial Disparity at End of Life and the ICUTexas State University; Department of Philosophy San Marcos, TX - 1/26/2015
- UT Southwestern Neurotherapeutics UpdateMedical Futility and Potentially Inappropriate Therapy - 1/14/2015
- Aggressive Management of Catastrophic Brain Injury1/13/2015
- Join now to see all
Press Mentions
- Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira ImmunologicsAugust 27th, 2020
Professional Memberships
- Member
- Neurocritical Care SocietyMember
- American Society for Bioethics and HumanitiesMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: